Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.03 Billion | USD 13.24 Billion | 11.36% | 2023 |
The global Allergy Diagnostics market size accrued earnings worth approximately USD 5.03 Billion in 2023 and is predicted to gain revenue of about USD 13.24 Billion by 2032, is set to record a CAGR of nearly 11.36% over the period from 2024 to 2032. The study includes drivers and restraints of the allergy diagnostics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the allergy diagnostics market on a global level.
In order to give the users of this report a comprehensive view of the allergy diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, where all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
An allergy is a hyperimmune response to certain products or substances. Allergies occur when a person’s immune system reacts to mild substances present in the environment. There are various different types of allergies, such as skin allergy, food allergy, dust allergy, pollen allergy, etc. These allergies can be fatal to a person under certain circumstances if left untreated. Various procedures that are used for allergy testing include blood tests, skin tests, etc., which helps healthcare professionals to provide treatment and instant relief to patients. Food allergy is caused due to the consumption of some proteins that may lead to discomfort and digestive problems. Drug allergy is caused due to the ingredients of some drugs that may reflect in the form of rashes, swelling, etc. These diagnostics help in the determination of allergic reactions and their treatment options. Some of the most commonly used diagnostics tests are intradermal, patch, prick, skin, and blood tests.
The major factor that contributes to the growth of the global allergy diagnostics market is the increased prevalence of allergy among people. As per Allergy UK 2015, around 20% of allergy patients live with a severe devastating form of their condition and fight with the distress of a most likely anaphylactic shock, asthma attack, or even death from an allergic reaction daily. Tremendous population rise is expected to increase allergic cases in the future. Furthermore, changing food habits, increasing geriatric population, favorable reimbursement scenario in developed economies, and rising awareness among people are expected to promote the global allergy diagnostics market. Moreover, increased healthcare expenditure and infrastructure coupled with changing lifestyles of people are also expected to boost the allergy diagnostic market globally over the forecast time period. On the other hand, various technological advancements are expected to create new growth opportunities for the growth of the allergy diagnostics market. However, the high cost and stringent regulatory approval process may inhibit the global allergy diagnostics market over the forecast time period.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, technology, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.
The global allergy diagnostics market is categorized into product type, allergen type, and end-user.
By product type, the allergy diagnostics market is segmented into luminometers, assay kits, immunoassay and ELISA analyzers, and services. Assay kits are expected to dominate the market in the future.
By allergen type, the allergy diagnostics market is fragmented into inhaled, food, and others. Inhaled allergens are expected to dominate the allergy diagnostics market.
By end-user, the allergy diagnostics market is segmented into hospitals, diagnostic laboratories, academic research institutes, and others. The hospitals segment is expected to develop rapidly over the estimated timeframe.
By region, North America is projected to lead the global allergy diagnostics market followed by Europe over the estimated timeframe. The Asia Pacific is expected to be the fastest developing region over the forecast period.
Allergy Diagnostics Market: Report Scope
Report Attributes | Report Details |
---|---|
Report Name | Allergy Diagnostics Market |
Market Size in 2023 | USD 5.03 Billion |
Market Forecast in 2032 | USD 13.24 Billion |
Growth Rate | CAGR of 11.36% |
Number of Pages | 202 |
Key Companies Covered | Alerchek Inc., Stallergenes SA, DST Diagnostische Systeme & Technologien GmbH, Lincoln Diagnostics Inc., Hitachi chemical Diagnostic Inc., Siemens Healthcare Diagnostics, Inc., BioMerieux, Inc., Hycor Biomedical Inc., Danaher Corp., HOB Biotech Group Co. Ltd., Omega Diagnostic, and Thermo Fisher Scientific Inc., among others |
Segments Covered | By product type, By Allergen Type, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some major players of the global allergy diagnostics market are -
This report segments the global allergy diagnostics market into:
Global Allergy Diagnostics Market: Product Type Analysis
Global Allergy Diagnostics Market: Allergen Type Analysis
Global Allergy Diagnostics Market: End-User Analysis
Global Allergy Diagnostics Market: Regional Analysis
FrequentlyAsked Questions
Global Allergy Diagnostics market size earned around $5.03 Bn in 2023 and is expected to reach $13.24 Bn by 2032
projected CAGR of 11.36%.
The largest share of the Allergy Diagnostics market is held by Asia Pacific. Developing countries of Asia Pacific such as China, Japan, and India will be dominating the market scenario mainly due to the rising constructional activities. The growth of Asia-Pacific region is expected to be followed by the Middle East and North America. Also, significant growth is expected from Western Europe owing to the developments taking place in this region especially in countries such as Italy, Germany, the U.K, France, and Spain. However, growth in Africa, Latin America, and Eastern Europe is anticipated to be moderate over the forecast period.
Alerchek Inc., Stallergenes SA, DST Diagnostische Systeme & Technologien GmbH, Lincoln Diagnostics Inc., Hitachi chemical Diagnostic Inc., Siemens Healthcare Diagnostics, Inc., BioMerieux, Inc., Hycor Biomedical Inc., Danaher Corp., HOB Biotech Group Co. Ltd., Omega Diagnostic, and Thermo Fisher Scientific Inc., among others
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed